Bradykinin (1-3) is a 3-amino acid residue peptide. Bradykinin (1-3) is an amino-truncated Bradykinin peptide, cleaved by Prolyl endopeptidase.
Bradykinin 1-3 is a peptide fragment derived from the N-terminus of the nonapeptide bradykinin, consisting of the first three amino acids of the parent molecule. As a tripeptide, it represents a key metabolic breakdown product generated through the enzymatic cleavage of bradykinin by kininases and other proteolytic enzymes. Its structure and origin make it highly relevant for research into peptide metabolism, signaling pathways, and the physiological roles of kinins in various biological systems. The study of this fragment provides valuable insight into the fate of vasoactive peptides and their regulatory mechanisms, supporting a wide range of investigations in biochemistry, pharmacology, and molecular biology.
Peptide metabolism studies: Bradykinin 1-3 serves as a crucial analytical standard and research tool for elucidating the enzymatic degradation pathways of bradykinin and related kinins. By enabling precise tracking of metabolic processes, it allows researchers to characterize the activity of kininases and other proteases responsible for peptide turnover. The use of this tripeptide fragment in in vitro assays aids in mapping the sequential cleavage events and identifying intermediate metabolites, contributing to a deeper understanding of peptide catabolism and its regulation in physiological and pathophysiological contexts.
Signal transduction research: As a product of bradykinin breakdown, the tripeptide is instrumental in studies investigating the downstream signaling consequences of kinin receptor activation and desensitization. Its presence and quantification in biological samples help delineate the temporal dynamics of bradykinin-mediated pathways. Researchers employ it to monitor the termination of kinin signaling and to explore how peptide fragmentation influences receptor interactions, second messenger cascades, and cellular responses, particularly in vascular, inflammatory, and pain-related processes.
Analytical method development: Bradykinin 1-3 is widely used as a reference compound for the development, validation, and calibration of analytical techniques such as liquid chromatography-mass spectrometry (LC-MS) and high-performance liquid chromatography (HPLC). Its defined structure and stability make it ideal for optimizing detection protocols for small peptides in complex biological matrices. By serving as a calibration standard or internal control, it enhances the accuracy and reproducibility of quantitative assays targeting kinin fragments and related biomolecules.
Enzymology and inhibitor screening: The tripeptide fragment is employed in enzymatic assays designed to evaluate the specificity and activity of peptidases involved in kinin metabolism. Researchers use it to assess the efficacy of enzyme inhibitors or modulators that target kininase pathways. By quantifying its formation or degradation in controlled systems, it becomes possible to characterize enzyme kinetics, substrate preferences, and the impact of experimental conditions on proteolytic processes relevant to kinin biology.
Peptide synthesis and functional studies: Bradykinin 1-3 is utilized as a model substrate in peptide synthesis protocols and as a tool in functional assays exploring the physicochemical properties of short peptides. Its sequence and attributes provide a basis for investigating peptide stability, solubility, and interactions with membranes or other biomolecules. Such studies inform the design of novel peptide analogs, facilitate structure-activity relationship analyses, and support the advancement of peptide-based research in both academic and industrial settings.
1. Cationic cell-penetrating peptides are potent furin inhibitors
4. Myotropic activity of allatostatins in tenebrionid beetles
5. Urinary Metabolites Associated with Blood Pressure on a Low-or High-Sodium Die
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More